CADL vs EQIX · $592.0M cap vs P/E 79, rev $5.07B
Candel Therapeutics Inc (CADL) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
CADL does not have a complete income-statement cache yet.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
CADL currently screens at market cap $592.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the CADL and EQIX stock pages for the full models.
Not investment advice.